Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Returning 247 results: Page 1 of 10


Tier Species Size Attr. GeneSet
Tier II 19130 GS238415: [MeSH] Genome Components : D040481
Tier II 19224 GS239190: [MeSH] Genome : D016678
Tier II 20142 GS241072: [MeSH] Genetic Phenomena : D055614
Tier II 19954 GS243722: [MeSH] Genetic Structures : D040342
Tier IV 9412 GS404756: Up regulated genes from caudate nucleus (from dorsal striatum) from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 8883 GS404759: Up regulated genes from putamen (from dorsal striatum) from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 8406 GS404762: Up regulated genes from ventral striatum from postmortem human brain tissue with Alcohol Use Disorder (AUD)
Tier IV 18653 GS407376: Dysregulation of NRSF/REST via EHMT1 is associated with psychiatric disorders and Kleefstra syndrome
Tier IV 12707 GS407573: Differentially expressed genes from Normal Retina Pigment Epithelium (RPE) compared to Normal Retina tissue in Age Related Macular Degeneration (AMD) patients
Tier III 19111 GS407935: Differentially expressed genes in human kidney tumors associated with extended opioid exposure_logFC
Tier III 17086 GS407944: Differentially expressed genes in opioid use disorder postmortem human brain_qvalue
Tier III 17086 GS407945: Differentially expressed genes in opioid use disorder postmortem human brain_log2FC
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier IV 9363 GS408182: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, log2FC
Tier IV 9363 GS408183: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10391 GS408184: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, log2FC
Tier IV 10391 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 9299 GS408186: Differential gene expression comparison between Carnegie Stages (CS) 17 and 22 during human embryo craniofacial development, log2FC
Tier IV 9299 GS408188: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10134 GS408189: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, log2FC
Tier IV 10134 GS408190: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier III 9636 GS409002: Differentially expressed genes in post-mortem human cuadate nucleus astrocytes of cocaine use disorder (CocUD) vs. control (p < 0.05)_pvalue
Tier III 9636 GS409003: Differentially expressed genes in post-mortem human cuadate nucleus astrocytes of cocaine use disorder (CocUD) vs. control (p < 0.05)_avg log2FC
Tier III 9636 GS409004: Differentially expressed genes in post-mortem human cuadate nucleus astrocytes of cocaine use disorder (CocUD) vs. control (p < 0.05)_qvalue